These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9632453)

  • 41. Oral contraceptives are a risk factor for cerebral vein thrombosis.
    Martinelli I; Rosendaal FR; Vandenbroucke JP; Mannucci PM
    Thromb Haemost; 1996 Sep; 76(3):477-8. PubMed ID: 8883291
    [No Abstract]   [Full Text] [Related]  

  • 42. The factor V Leiden and prothrombin G20210A mutations in Kirghiz population.
    Gurgey A; Kudayarov DK; Tuncer M; Parlak H; Altay C
    Thromb Haemost; 2000 Aug; 84(2):356. PubMed ID: 10959716
    [No Abstract]   [Full Text] [Related]  

  • 43. Prothrombin gene variant (G20210A) in a patient with cerebral venous sinus thrombosis.
    van Krimpen J; Leebeek FW; Dippel DW; Gomez Garcia E
    Clin Neurol Neurosurg; 1999 Mar; 101(1):53-5. PubMed ID: 10350206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral contraceptives and the risk of myocardial infarction.
    Tanis BC
    Eur Heart J; 2003 Mar; 24(5):377-80. PubMed ID: 12633537
    [No Abstract]   [Full Text] [Related]  

  • 45. Factor V Leiden mutation and venous thrombosis.
    Hatake K; Miura Y
    Lancet; 1995 Jan; 345(8942):133. PubMed ID: 7815876
    [No Abstract]   [Full Text] [Related]  

  • 46. Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutation.
    Brey RL; Coull BM
    Stroke; 1996 Oct; 27(10):1719-20. PubMed ID: 8841316
    [No Abstract]   [Full Text] [Related]  

  • 47. Oral contraceptives and vascular disease.
    Coon WW
    Univ Mich Med Cent J; 1968; 34(4):190-3. PubMed ID: 4879130
    [No Abstract]   [Full Text] [Related]  

  • 48. Cerebral venous thrombosis and activated protein C resistance.
    Sánchez del Rio M; Gómez-Tortosa E; Outeriño J
    J Neurol; 1996 Oct; 243(10):727-8. PubMed ID: 8923308
    [No Abstract]   [Full Text] [Related]  

  • 49. Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebral venous thrombosis 1 month after resumption of the medication at the age of 50.
    Tormene D; Simioni P; Sartori MT; Girolami A
    Blood Coagul Fibrinolysis; 2001 Mar; 12(2):161-2. PubMed ID: 11302480
    [No Abstract]   [Full Text] [Related]  

  • 50. Ischemic colitis associated with factor V Leiden mutation.
    Yee NS; Guerry D; Lichtenstein GR
    Ann Intern Med; 2000 Apr; 132(7):595-6. PubMed ID: 10744608
    [No Abstract]   [Full Text] [Related]  

  • 51. Cerebral sinus thrombosis and oral contraceptives. There are limits to predictability.
    Vandenbroucke JP
    BMJ; 1998 Aug; 317(7157):483-4. PubMed ID: 9712588
    [No Abstract]   [Full Text] [Related]  

  • 52. Homozygous 20210G/A prothrombin gene mutation associated with bilateral iliac vein thrombosis: a case report.
    Vayá A; García M; Mira Y; Ferrando F; Villa P; Estellés A; Aznar J
    Thromb Res; 2001 Nov; 104(4):293-6. PubMed ID: 11728531
    [No Abstract]   [Full Text] [Related]  

  • 53. [Presence of G1691A mutation on the gene of factor V in arterial thrombosis].
    Lellouche F; Dorval I; Dewilde J; Van Walleghem E
    Presse Med; 1995 May; 24(18):869. PubMed ID: 7638121
    [No Abstract]   [Full Text] [Related]  

  • 54. Cerebral venous thrombosis in young adults. Experience in a stroke unit, 1988-1994.
    Partziguian T; Camerlingo M; Castro L; Censori B; Gazzaniga GC; Belloni G; Mamoli A
    Ital J Neurol Sci; 1996 Dec; 17(6):419-22. PubMed ID: 8978448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral contraceptives and the risk of thrombosis.
    Dommisse J
    S Afr Med J; 1979 Nov; 56(20):786. PubMed ID: 505216
    [No Abstract]   [Full Text] [Related]  

  • 56. Recent advances in haematology.
    Provan D; O'Shaughnessy DF
    BMJ; 1999 Apr; 318(7189):991-4. PubMed ID: 10195974
    [No Abstract]   [Full Text] [Related]  

  • 57. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
    Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
    Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Case reports: heritable thrombophilia associated with deep venous thrombosis after shoulder arthroscopy.
    Bongiovanni SL; Ranalletta M; Guala A; Maignon GD
    Clin Orthop Relat Res; 2009 Aug; 467(8):2196-9. PubMed ID: 19452233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombophilias and arteriovenous fistula dysfunction in maintenance hemodialysis.
    Danis R; Ozmen S; Akin D; Batun S; Kahvecioglu S; Altintas A; Yilmaz ME; Polat A
    J Thromb Thrombolysis; 2009 Apr; 27(3):307-15. PubMed ID: 18363036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thrombophilia and pregnancy.
    Kupferminc MJ
    Reprod Biol Endocrinol; 2003 Nov; 1():111. PubMed ID: 14617365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.